I must say I get a bit cross when posters suggest I post falsehoods!
"An FDA spokesperson told Reuters in an email response that the FDA had sent letters to some firms, not all, deferring further reviews of applications due to a list of issues."
"For firms that received letters, they do not mean that the infant formulas are unsafe; rather, they indicate that we have found issues that would unlikely be resolved quickly," the spokesperson said.
https://www.reuters.com/business/healthcare-pharmaceuticals/nzs-a2-milk-says-fda-deferred-request-supply-baby-formula-2022-08-09/
Deferral is not rejection! This looks like a pause whilst they clean house, page-21
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$7.79 |
Change
-0.010(0.13%) |
Mkt cap ! $5.589B | |||
| Open | High | Low | Value | Volume |
| $7.87 | $7.87 | $7.71 | $8.613M | 1.109M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 4106 | $7.79 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.80 | 5200 | 8 |
View Market Depth
| Last trade - 15.17pm 27/06/2025 (20 minute delay) ? |
| A2M (ASX) Chart |